Merck’s Keytruda holds on to the top spot while AbbVie’s Humira—once the world’s top-selling drug—continues to cede its ...

ANSWER: Gabapentin was originally approved as a drug to control epilepsy, but it soon became clear that it was useful for chronic pain, especially the kind that comes from damaged nerves. But it can ...

In 2016, I was fortunate to survive a saddle pulmonary embolism (PE). I was sent home from the hospital with an Eliquis ...

In people with a life-threatening clot and no identification of what caused it, or if something caused it that can't be fixed ...

A. Eliquis (apixaban) is a lifesaving anticoagulant that reduces the risk of blood clots that could cause a stroke. The price in the U.S. is more than $600 for a month’s supply. That’s with a coupon ...

Warfarin was associated with more risk than apixaban (Eliquis; 55.38 vs 21.42 per 1,000 person-years, HR 2.60, 95% CI ...

Kathy Davis of Canonsburg underwent heart surgery, but complications left her with right heart failure, a condition where the ...

False Belief 1: Drug experimentation is normal for teens and shouldn’t alarm parents. Drug use and experimentation among teens often is ignored by many—even parents, who then may be unaware ...

Expected out-of-pocket costs for commonly prescribed brand name medications have grown substantially for Medicare Part D beneficiaries as drug plans increasingly tie patient costs to list prices, ...

Taho Pharmaceuticals’s apixaban-based oral dissolving strips ... now plans to use these results to push ahead with a new drug application (NDA) and a marketing authorisation application (MAA ...

Dr. Mitchell said, "For example, apixaban (a DOAC) has a lower risk of significant bleeding than warfarin, so for many older patients with AF, this would be an excellent medication. "Our findings ...

Taho Pharmaceuticals plans to use these results to push ahead with a new drug application (NDA) and a marketing authorisation application (MAA) before the FDA. Credit: Shutterstock / BioFoto. Taho ...